Hims & Hers stock tumbled after the company confirmed it would stop selling some compounded weight-loss drugs.
The report suggests compounders may be using illegally imported APIs made in unregistered overseas facilities.
Markets fell broadly Tuesday with the S&P 500 trading at five-week lows and the Nasdaq extending its three-day losing streak.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback